Amgen (AMGN): FY25 Q3 earnings call, Nov 4, 2025
No Kalshi or Polymarket word markets were listed for Amgen’s Nov 4, 2025 earnings call (FY25 Q3). The transcript is searchable below (quotes of at most 25 words).
UpdatedTranscript
quotes of at most 25 wordsSpeaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.
2 matches for “Prolia”; 1 quoted, at least 25 words apart.
…and increased treatment could meaningfully expand patient reach and drive continued growth. Prolia delivered $1.1 billion in sales, an increase of 9% year-over-year. Three biosimilars…
Agents: this page as TSV at /api/v1/appearances/amgen:2025-11-04:earnings_call · words: /api/v1/brief?appearance=amgen:2025-11-04:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP